University of Manchester: Clinical Trials

406 trials sponsored by University of Manchester, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

202 completed, 90 unknown, 50 recruiting, 25 not yet recruiting. 216 Not applicable, 39 Phase 2, 25 Phase 3, 18 Phase 1, 11 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable216Completed 120, Unknown 49, Recruiting 13, Not yet recruiting 12, Terminated 10, Withdrawn 6, Active not recruiting 4, Suspended 2
Phase 239Completed 16, Recruiting 8, Unknown 5, Terminated 4, Active not recruiting 2, Not yet recruiting 2, Withdrawn 2
Phase 325Completed 11, Recruiting 10, Terminated 2, Unknown 2
Phase 118Completed 10, Unknown 3, Active not recruiting 2, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 411Completed 10, Terminated 1

Follow University of Manchester: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cervical Cancer Awareness Education to Aid Confidence and Screening upTake (ACT): A Pilot Randomised Control Trial
cervical cancer Awareness education to aid Confidence and screening upTake (ACT), Control group - Anxiety, Cervical Cancer Screening
Not applicableNot yet recruitingTeesside University762026-10-122026-10-07
EpiSign International: Expanding Epigenomic Testing in Rare Disease
Integrated EPIC/CNV microarray with EpiSign analysis, EpiSign analysis with EPIC DNA methylation microarray - Rare Disease, Undiagnosed Disease
Not yet recruitingUniversity of Manchester1922026-10-012026-09-24
Prescribing the Right Agent for Depression in Adults
PRADA Tool, PETRUSHKA Tool - Major Depressive Disorder (MDD)
Not applicableNot yet recruitingUniversity of Oxford21422026-10-012026-10-09
proState Cancer Health Education to pRomote Early sreENing Uptake (SCREEN): A Pilot Randomised Control Trial
proState Cancer awareness education to pRomote Early screENing uptake, Control group - Anxiety, Prostate Cancer
Not applicableNot yet recruitingTeesside University742026-09-152026-09-02
Building a Computational Model of Auditory Hallucinations
Schizophrenia / Schizoaffective Disorder, Schizophrenia and Disorders With Psychotic Feature
Not yet recruitingKing's College London1462026-09-012026-09-15
Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer
Abiraterone, Apalutamide, Enzalutamide or Darolutamide (ARPI therapy) (per standard of care) therapy - Prostate Cancer, mHSPC
Phase 3RecruitingUniversity College, London15002026-08-282026-10-16
Action Falls for Domiciliary Care
Falls
RecruitingUniversity of Nottingham652026-07-152026-07-24
Precision Pharmacogenetics and Genotype Class Based Prediction of Mavacamten Response in Obstructive Hypertrophic Cardiomyopathy
Observational study, no new intervention offered - Hypertrophic Cardiomyopathy (HCM)
Not yet recruitingUniversity of Manchester1402026-06-012026-02-13
Using IF-THEN Plans to Support Healthcare Professionals in Raising Patient Safety Concerns
Implementation intention planning - Patient Safety Concerns
Not applicableNot yet recruitingUniversity of Manchester10002026-05-312026-04-23
St Mary's Assisted Reproductive Technology and Cardiometabolic Health: Modifiable Targets for Multimorbidity Prevention (START-HEALThY)
Maternal Cardiometabolic Health, Infertility
Not yet recruitingUniversity of Manchester1202026-05-012026-04-28
The Mouth Matters in Mental Health Trial -2
Link work intervention - Mental Health, Oral Health Care
Not applicableRecruitingLancashire and South Cumbria NHS Foundation Trust4802026-05-012026-07-27
Myocardial Energetic Restoration in the Treatment of Obstructive Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy (HCM)
Not yet recruitingUniversity of Manchester202026-04-302026-01-12
Media Orientation to Improve Childhood Vaccine Uptake and Address Parent and Caregivers Vaccine-related Anxiety: A Pilot Study
ASSURed awareness campaign to encourage childhood vaccine uptakE (ASSURE) intervention, Intervention as usual - Anxiety, Vaccination Hesitancy
Not applicableNot yet recruitingTeesside University742026-04-202026-04-03
DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
Dabrafenib, Trametinib - Haematological Malignancy, Malignant Neoplasm
Phase 2 / Phase 3RecruitingCancer Research UK302026-04-012026-08-17
Multicentre Hypertrophic Cardiomyopathy Registry
Hypertrophic Cardiomyopathy (HCM)
RecruitingUniversity of Manchester25002026-04-012026-05-01
Positron Emission Tomography to Assess the Effect of Camzyos on Ischaemia in HOCM: PEACH Trial
Camzyos (Mavacamten) - Hypertrophic Obstructive Cardiomyopathy \(HOCM\), Left Ventricular Outflow Tract Obstruction
Not applicableRecruitingUniversity of Manchester752026-03-262026-05-22
Using IF-THEN Plans to Support Patients in Raising Safety Concerns About Their Care
Implementation intention planning - Patient Safety Concerns
Not applicableNot yet recruitingUniversity of Manchester100002026-03-202026-03-19
A Feasibility Randomised Control Trial to Evaluate Early Perinatal Bereavement Counselling for Parents Who Have Experienced a Perinatal Death
Bereavement Counselling, Usual bereavement care - Stillbirth, Perinatal Death
Not applicableNot yet recruitingUniversity of Manchester262026-03-012026-03-27
A Case Series of Culturally-adapted CBTp for Black People in the UK
Culturally-adapted cognitive-behavioural therapy - Psychosis, Schizophrenia Spectrum Disorders
Not applicableRecruitingUniversity of Manchester62026-02-242026-07-10
GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia
Cord blood transplantation + conditioning + granulocytes of variable days according to study design - Acute Myeloid Leukemia, Stem Cell Transplantation
Phase 1 / Phase 2Not yet recruitingUniversity of Manchester502026-02-092026-03-11

Showing 20 of 406. Sign in to see all of them.

Conditions studied

Anxiety Disorders (29)  ·  Depression (28)  ·  Neoplasms (23)  ·  Psychotic Disorders (19)  ·  Schizophrenia (14)  ·  Self-Injurious Behavior (13)  ·  Lung Neoplasms (11)  ·  Colorectal Neoplasms (10)  ·  Melanoma (10)  ·  Motor Activity (10)  ·  Psychological Well-Being (10)  ·  Stroke (10)  ·  Carcinoma, Non-Small-Cell Lung (8)  ·  Breast Neoplasms (7)  ·  COVID-19 (7)

Interventions

Therapeutics (7)  ·  Psychosocial Intervention (5)  ·  Blood Specimen Collection (4)  ·  Standard of Care (4)  ·  Surveys and Questionnaires (4)  ·  Hematologic Tests (3)  ·  Ketamine (3)  ·  Magnetic Resonance Imaging (3)  ·  Methods (3)  ·  Observation (3)  ·  Sodium Chloride (3)  ·  Transcranial Direct Current Stimulation (3)  ·  Trastuzumab (3)  ·  Aspirin (2)  ·  Behavior Therapy (2)

Countries

United Kingdom (325)  ·  Pakistan (14)  ·  United States (7)  ·  Spain (6)  ·  Canada (5)  ·  Italy (5)  ·  Australia (4)  ·  Norway (4)  ·  France (3)  ·  Switzerland (3)  ·  Belarus (2)  ·  Germany (2)  ·  Netherlands (2)  ·  Austria (1)  ·  Belgium (1)

Top investigators

Matthew Krebs, Dr (7)  ·  Nusrat Husain, MD (5)  ·  Adrian Wells (4)  ·  Farooq Naeem, MRCPsych (4)  ·  Imran Chaudhry, MD (4)  ·  Munir Hamirani, FCPS (4)  ·  Adrian Wells, PhD (3)  ·  Alex Molassiotis, MD (3)  ·  Alun H Davies (2)  ·  Ananya Choudhury, Professor (2)  ·  Bill Deakin, Prof (2)  ·  Chris Armitage, PhD (2)  ·  Christopher Armitage, PhD (2)  ·  Christopher J Armitage (2)

Results publications

PMID 33884617, PMID 35722590, PMID 14551293, PMID 18685543, PMID 18823182, PMID 18828921, PMID 19109497, PMID 19782876, PMID 19815630, PMID 20087360, PMID 21084399, PMID 21246515, PMID 22031888, PMID 22445135, PMID 22971152, PMID 23109700, PMID 23351338, PMID 23364005, PMID 23436910, PMID 24311515, PMID 24439297, PMID 24676964, PMID 24885461, PMID 25306116, PMID 25721307, PMID 25744334, PMID 26087670, PMID 26113113, PMID 26178731, PMID 26454512, PMID 26554558, PMID 26603604, PMID 26720064, PMID 27094189, PMID 27133029, PMID 27403996, PMID 27820636, PMID 27857687, PMID 27871302, PMID 27881788, PMID 28119390, PMID 28155203, PMID 28188239, PMID 29166928, PMID 29207980, PMID 29306872, PMID 29378526, PMID 29540225, PMID 29733403, PMID 29757799

NIH funding

2016 (3), 2018 (3), 2009 (2), 1DP3DK104386-01 (1), 2008 (1), 2023 (1), 2025 (1), R01DC015997 (1), R21DK104127 (1), U01HD061234 (1)